Stock listing

Frankfurt:UNC0 Ucb S.A. Aktie

German listing (Frankfurt) of Ucb S.A. · home listing Euronext:UCB

Follow Ucb S.A. into a list and get an email when it puts out news.

Share price · FWB:UNC0

€140.00 EUR -3.00 (-2.1%)

Close on Nov 20, 2026

Past year +25.3% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€140.00 – €140.00 EURNov 20, 2026
Market cap
€53.30B EURAt the close on Nov 20, 2026 · price × 380.7M shares outstanding
52-week range
€97.72 – €144.26 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€3,796 EURMedian day 0 shares · 55 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Ucb S.A. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:UCB · Home€279.60 EUR-5.50 (-1.9%)252,719€280.50€283.70€277.40€285.10Close on Nov 20, 2026
OTC:UCBJY$151.52 USD-3.44 (-2.2%)2,867$153.91$153.91$151.52$154.96Close on Nov 20, 2026
OTC:UCBJF$318.32 USD-3.77 (-1.2%)19$318.32$318.32$318.32$322.09Close on Nov 20, 2026
Frankfurt:UNC€277.80 EUR-8.30 (-2.9%)60€280.30€282.40€277.80€286.10Close on Nov 20, 2026
Dusseldorf:UNC€277.00 EUR-4.80 (-1.7%)—€279.60€282.60€277.00€281.80Close on Nov 20, 2026
Frankfurt:UNC0€140.00 EUR-3.00 (-2.1%)—€140.00€140.00€140.00€143.00Close on Nov 20, 2026
Munich:UNC€279.50 EUR-7.50 (-2.6%)—€280.30€280.30€279.50€287.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:UNC0 · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€144.26+2.35+1.7%€144.26€144.26€144.260
€141.91+4.32+3.1%€141.91€141.91€141.910
€137.59+0.143+0.1%€137.59€137.59€137.590
€137.44-1.706-1.2%€137.44€137.44€137.440
€139.15+0.903+0.7%€139.15€139.15€139.150
€138.25+3.806+2.8%€138.25€138.25€138.250
€134.44+0.351+0.3%€134.44€134.44€134.440
€134.09-0.197-0.1%€134.09€134.09€134.090
€134.29-2.218-1.6%€134.29€134.29€134.290
€136.51+8.494+6.6%€136.51€136.51€136.5130
€128.01+1.801+1.4%€128.01€128.01€128.010
€126.21+17.92+16.6%€115.70€126.39€115.491,682
€108.29+6.219+6.1%€108.29€108.29€108.290
€102.07-0.494-0.5%€102.07€102.07€102.070
€102.56+1.173+1.2%€102.56€102.56€102.560
€101.39+0.839+0.8%€101.39€101.39€101.390
€100.55+2.825+2.9%€100.55€100.55€100.550
€97.72-2.969-2.9%€97.72€97.72€97.720
€100.69-1.333-1.3%€100.69€100.69€100.690
€102.03+1.125+1.1%€102.03€102.03€102.030
€100.90-0.29-0.3%€100.90€100.90€100.900
€101.19+0.292+0.3%€101.19€101.19€101.190
€100.90+1.584+1.6%€100.90€100.90€100.900
€99.31-2.05-2.0%€99.31€99.31€99.310
€101.36+0.292+0.3%€101.36€101.36€101.360
€101.07-0.683-0.7%€101.07€101.07€101.070
€101.76-0.899-0.9%€101.76€101.76€101.760
€102.65-3.202-3.0%€102.65€102.65€102.650
€105.86+0.111+0.1%€105.86€105.86€105.860
€105.75+0.07+0.1%€105.75€105.75€105.750
€105.68+0.988+0.9%€105.68€105.68€105.680
€104.69-1.498-1.4%€104.69€104.69€104.690
€106.19-0.253-0.2%€106.19€106.19€106.190
€106.44+2.40+2.3%€106.44€106.44€106.440
€104.04+0.336+0.3%€104.04€104.04€104.040
€103.70+0.393+0.4%€103.70€103.70€103.700
€103.31-1.713-1.6%€103.31€103.31€103.310
€105.02-0.383-0.4%€105.02€105.02€105.020
€105.41+3.498+3.4%€105.41€105.41€105.410
€101.91+1.548+1.5%€101.91€101.91€101.910
€100.36-1.502-1.5%€100.36€100.36€100.360
€101.86-1.096-1.1%€101.86€101.86€101.860
€102.96-0.071-0.1%€102.96€102.96€102.960
€103.03-1.216-1.2%€103.03€103.03€103.030
€104.24-5.297-4.8%€104.24€104.24€104.240
€109.54-1.097-1.0%€109.54€109.54€109.540
€110.64+1.787+1.6%€110.64€110.64€110.640
€108.85+2.394+2.2%€108.85€108.85€108.850
€106.46-0.711-0.7%€106.46€106.46€106.460
€107.17-3.317-3.0%€107.17€107.17€107.170
€110.49+0.689+0.6%€110.49€110.49€110.490
€109.80-1.961-1.8%€109.80€109.80€109.800
€111.76+2.248+2.1%€111.76€111.76€111.760
€109.51-0.213-0.2%€109.51€109.51€109.510
€109.72+1.248+1.2%€109.72€109.72€109.720
€108.47-0.208-0.2%€108.47€108.47€108.470
€108.68+0.678+0.6%€108.68€108.68€108.680
Ticker
Frankfurt:UNC0
Asset type
Stock
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Ucb S.A. news

Ucb S.A. on 6ix

News releases
29 in the last 12 months · 39 in all · newest Sep 30, 2026 · oldest 2025
Decks
41 decks · latest Jul 30, 2026

Where Ucb S.A. is listed

ListingExchangeCountryCurrency
Euronext:UCB · Home listingEuronextBelgiumEUR
OTC:UCBJYOTCUnited StatesUSD
gettex:UNCgettexGermanyEUR
OTC:UCBJFOTCUnited StatesUSD
LSIN:0NZTLSINUnited KingdomEUR
Xetra:UNCXetraGermanyEUR
BX Swiss:UNCBX SwissSwitzerlandCHF
Tradegate:UNCTradegateGermanyEUR
Lang & Schwarz:852738Lang & SchwarzGermanyEUR
LS Exchange:852738LS ExchangeGermanyEUR
EUROTLX:4UCBEUROTLXItalyEUR
VIE:UCBViennaAustriaEUR
Frankfurt:UNCFrankfurtGermanyEUR
Dusseldorf:UNCDusseldorfGermanyEUR
Frankfurt:UNC0 · This pageFrankfurtGermanyEUR
Turquoise:UCBBTurquoiseUnited KingdomEUR
Munich:UNCMunichGermanyEUR
Aquis:UCBBAquisUnited KingdomEUR
Hamburg:UNCHamburgGermanyEUR
Aquis:UCBBAquisUnited KingdomEUR
BIVA:UCBNBIVAMexicoMXN
BMV:UCBNBMVMexicoMXN
Dusseldorf:UNC0DusseldorfGermanyEUR
Lang & Schwarz:A14WZYLang & SchwarzGermanyEUR
LS Exchange:A14WZYLS ExchangeGermanyEUR
Stuttgart:UNCStuttgartGermanyEUR
Stuttgart:UNC0StuttgartGermanyEUR
Hanover:UNCHanoverGermanyEUR

Valuation

Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
€56.10B EUR
P/E
34.2×
EV/sales
7.3×
EV/EBITDA
31.3×
Price/book
4.6×
Gross margin
71.1%
Operating margin
15.1%
Net margin
20.1%
Debt to equity
0.3×
Beta
No index for this market yet

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
298.63 EUR · Analysts' mean
EPS, year to Dec 2026
13.19 · 17 analysts
Revenue, year to Dec 2026
9.1B · 16 analysts

Team and board

Officers

OfficerRole
Jean-Christophe TellierChief Executive Officer & Chairman of the Executive Committee
Sandrine DufourExecutive Vice President, Chief Financial Officer
Denelle J. Waynick JohnsonExecutive Vice President & General Counsel
Anna ClarkCorporate Communications, Media Relations
Antje WitteInvestor Relations
Fayos AlonsoCorporate Communications, Media Relations
Laurent SchotsCorporate Communications, Media Relations
Sahar YazdianCorporate Communications
Yvonne NaughtonInvestor Relations
Alistair HenryExecutive Vice President & Chief Scientific Officer
Emmanuel CaeymaexExecutive Vice President
Fiona du MonceauExecutive Vice President, Chief Commercial Officer
Jacques MarbehantExecutive Vice President, Patient Supply
Jean Luc FleurialExecutive Vice President & Chief Human Resources Officer

Board

DirectorRole
Jonathan PeacockIndependent Director, Chair of the Board
Cédric van RijckevorselDirector
Charles-Antoine JanssenDirector, Vice-chair of the Board
Cyril JanssenDirector
Dolca ThomasIndependent Director
Fiona PowrieIndependent Director
Jan BergerIndependent Director
Jean-Christophe TellierChief Executive Officer & Chairman of the Executive Committee
Judy BrownIndependent Director, Chair of the Audit Committee
Maëlys CastellaIndependent Director
Nefertiti GreeneIndependent Director
Pierre GurdjianIndependent Director
Stef HeylenDirector
Ulf WiinbergIndependent Director

Events

Next results
Feb 25, 2027 (expected)
QuarterResultsShare move
Q4 2025Dec 31, 2025−1.2%
Quarter to Sep 30, 2025Nov 28, 2025+0.5%
Q2 2025Jul 31, 2025 · After close−2.9%
Quarter to Mar 31, 2025May 30, 2025+4.3%
Q4 2024Feb 27, 2025−0.3%
Quarter to Sep 30, 2024Nov 29, 2024+1.9%
Q2 2024Jul 25, 2024+3.8%
Quarter to Mar 31, 2024Apr 25, 2024 · After close−0.4%
Q4 2023Feb 28, 2024 · After close+1.4%
Quarter to Sep 30, 2023Oct 31, 2023−1.3%
All 20 quarters
QuarterResultsShare move
Q2 2023Jul 27, 2023 · Before open+0.1%
Q1 2023Apr 26, 2023−2.7%
Q4 2022Feb 22, 2023 · Before open+2.4%
Q3 2022Nov 1, 2022+0.2%
Q2 2022Jul 28, 2022 · Before open−4.0%
Q1 2022Apr 27, 2022+2.1%
Q4 2021Feb 24, 2022+8.7%
Q3 2021Nov 2, 2021+2.5%
Q2 2021Jul 28, 2021 · After close+1.4%
Q1 2021Apr 28, 2021−2.5%

Open Events

Decks

DeckKindSlidesDate
H1 2026 Earnings PresentationEarnings22 slidesJul 30, 2026
FY2025 Earnings PresentationEarnings22 slidesFeb 26, 2026
44th Annual J.P. Morgan Healthcare Conference 2026Conference16 slidesJan 14, 2026
H1 2025 Earnings PresentationEarnings21 slidesJul 31, 2025
FY2024 Earnings PresentationEarnings18 slidesFeb 27, 2025
43rd Annual J.P. Morgan Healthcare Conference (January 2025)Conference13 slidesJan 15, 2025
ESG Presentation (November 2024)Sustainability48 slidesNovember 2024
H1 2024 Earnings PresentationEarnings19 slidesJul 25, 2024
FY2023 Earnings PresentationEarnings22 slidesFeb 28, 2024
42nd Annual J.P. Morgan Healthcare Conference (January 2024)Conference10 slidesJan 9, 2024
All 41 decks
DeckKindSlidesDate
ESG Presentation (November 2023)Sustainability51 slidesNovember 2023
H1 2023 Earnings PresentationEarnings19 slidesJul 27, 2023
Technical Presentation (March 2023)Technical32 slidesMarch 2023
FY2022 Earnings PresentationEarnings42 slidesFeb 22, 2023
Investor Day (January 2023)Investor day29 slidesJan 9, 2023
ESG Presentation (November 2022)Sustainability50 slidesNovember 2022
Technical Presentation (November 2022)Technical40 slidesNovember 2022
31st EADV Congress 2022Conference40 slidesSeptember 2022
H1 2022 Earnings PresentationEarnings30 slidesJul 28, 2022
Technical Presentation (May 2022)Technical59 slidesMay 2022
FY2021 Earnings PresentationEarnings37 slidesFeb 24, 2022
Merger or Acquisition (January 2022)Merger or acquisition22 slidesJan 19, 2022
H1 2021 Earnings PresentationEarnings32 slidesJul 29, 2021
Shareholder Meeting (April 2021)Shareholder meeting12 slidesApr 29, 2021
Investor Presentation (June 2020)Investor deck63 slidesJune 2020
H1 2019 Earnings PresentationEarnings50 slidesJul 25, 2019
FY2017 Earnings PresentationEarnings53 slidesFeb 22, 2018
H1 2017 Earnings PresentationEarnings41 slidesJul 27, 2017
Q1 2017 Earnings PresentationEarnings37 slidesApr 24, 2017
Q1 2016 Earnings PresentationEarnings41 slidesApr 25, 2016
Investor Presentation (September 2014)Investor deck40 slidesSeptember 2014
FY2013 Earnings PresentationEarnings44 slidesFeb 26, 2014
Investor Presentation (April 2011)Investor deck63 slidesApril 2011
H1 2010 Earnings PresentationEarnings60 slidesAug 2, 2010
H1 2010 Earnings PresentationEarnings62 slidesAug 2, 2010
FY2009 Earnings PresentationEarnings68 slidesMar 2, 2010
H1 2009 Earnings PresentationEarnings45 slidesJul 31, 2009
Investor Presentation (June 2009)Investor deck47 slidesJune 2009
Technical Presentation (2009)Technical24 slides2009
Technical Presentation (2009)Technical25 slides2009
Investor Presentation (November 2008)Investor deck42 slidesNovember 2008

Open Decks

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue7.74B6.15B5.25B5.52B5.78B5.35B4.91B4.63B4.47B4.15B
Cost of revenue2.23B1.75B1.71B1.67B1.44B1.36B1.43B1.20B1.20B1.20B
Gross profit5.51B4.40B3.54B3.84B4.34B3.98B3.49B3.43B3.27B2.94B
Research and development1.82B1.78B1.63B1.67B1.63B1.57B1.27B1.16B1.06B1.02B
Selling, general and administrative264.0M272.0M230.0M225.0M208.0M196.0M195.0M180.0M192.0M184.0M
Operating income1.17B1.32B604.0M585.0M1.28B971.0M1.08B1.11B1.07B796.0M
Depreciation and amortization627.0M641.0M691.0M589.0M323.0M354.0M313.0M288.0M234.0M232.0M
EBITDA1.79B1.97B1.29B1.17B1.61B1.32B1.40B1.40B1.31B1.03B
Interest expense128.0M200.0M210.0M112.0M138.0M107.0M60.0M62.0M56.0M87.0M
Income before tax1.82B1.16B441.0M511.0M1.23B880.0M961.0M1.01B988.0M764.0M
Income tax264.0M98.0M98.0M91.0M170.0M119.0M146.0M200.0M218.0M199.0M
Net income1.56B1.06B343.0M418.0M1.06B732.0M792.0M800.0M753.0M520.0M
Earnings per share, basic8.205.611.812.205.603.874.234.244.002.76
Earnings per share, diluted5.481.762.145.453.77

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents2.25B1.57B861.0M899.0M1.26B1.34B329.0M1.26B1.05B761.0M
Short-term investments219.0M184.0M108.0M170.0M110.0M704.0M989.0M17.0M14.0M46.0M
Receivables1.79B1.53B1.22B1.05B1.24B1.03B707.0M632.0M738.0M820.0M
Inventory1.50B1.31B1.03B907.0M878.0M854.0M780.0M647.0M597.0M578.0M
Current assets6.05B4.79B3.44B3.30B3.71B3.58B3.29B2.95B2.68B2.33B
Property, plant and equipment1.75B1.59B1.43B1.27B1.03B840.0M805.0M673.0M678.0M
Goodwill5.09B5.46B5.25B5.34B5.17B4.96B5.06B4.97B4.84B5.18B
Total assets18.2B17.3B15.5B15.9B14.2B13.3B11.1B10.5B9.92B10.2B
Accounts payable817.0M3.02B2.31B2.49B2.56B2.14B403.0M364.0M281.0M274.0M
Current liabilities4.40B3.53B2.62B3.11B2.82B2.81B2.39B2.15B1.95B2.42B
Long-term debt2.06B2.82B2.88B2.54B1.25B1.63B914.0M1.29B1.53B1.57B
Total debt2.25B3.03B3.04B2.90B1.31B1.71B1.28B1.50B1.57B1.60B
Total liabilities7.29B7.32B6.56B6.80B5.82B6.05B4.07B4.26B4.18B4.74B
Shareholders' equity10.9B10.0B8.97B9.06B8.39B7.27B7.04B6.31B5.81B5.58B
Shares outstanding190.0M195.0M195.2M194.8M194.2M194.2M187.2M188.5M188.3M188.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations2.16B1.24B761.0M1.12B1.55B1.08B882.0M1.09B927.0M427.0M
Capital spending-281.0M-234.0M-238.0M-252.0M-282.0M-256.0M-294.0M-94.0M-100.0M-108.0M
Free cash flow1.88B1.01B523.0M867.0M1.27B825.0M588.0M995.0M827.0M319.0M
Cash from investing-389.0M282.0M-440.0M-1.58B-487.0M-2.23B-235.0M-320.0M-228.0M317.0M
Cash from financing-1.09B-818.0M-308.0M70.0M-1.12B1.18B-605.0M-538.0M-402.0M-1.27B
Dividends paid-264.0M-259.0M-252.0M-247.0M-240.0M-235.0M-228.0M-222.0M-217.0M-231.0M
Share buybacks-121.0M-162.0M-40.0M-42.0M-60.0M-106.0M-77.0M-51.0M-105.0M-49.0M
Change in cash678.0M706.0M13.0M-391.0M-53.0M30.0M51.0M215.0M266.0M-521.0M

Open Financials

Cap table

Built by 6ix from Ucb S.A.’s releases

Common shares
190,662,572
Fully diluted
190,662,572

Fully diluted

LineShares
Common shares190,662,572

Share count over time

CountShares
Nov 22, 2026190,662,572

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Rhumbline Advisers11,028US$1.28MSep 30, 2026
GAMMA Investing LLC1,566US$182KSep 30, 2026
Atlas Capital Advisors Inc.470US$36,879Sep 30, 2026
Calydon Capital194US$22,504Sep 30, 2026
First Command Advisory Services, Inc.104US$12,064Sep 30, 2026
Hantz Financial Services, Inc.57US$7,000Sep 30, 2026
Ascentis Wealth Management, LLC48US$5,568Sep 30, 2026
PNC Financial Services Group, Inc.13US$1,508Sep 30, 2026

Funds

HolderSharesValueAs of
Vanguard Health Care Fund2.48MUS$637MJul 31, 2026
Vanguard Total International Stock Index Fund1.77MUS$453MJul 31, 2026
Fidelity Contrafund1.49MUS$445MJun 30, 2026
Vanguard Developed Markets Index Fund1.17MUS$351MJun 30, 2026
Fidelity Series Large Cap Stock Fund1.13MUS$339MJun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund1.09MUS$319MMay 31, 2026
iShares Core MSCI EAFE ETF909KUS$233MJul 31, 2026
Strategic Advisers Fidelity International Fund832KUS$244MMay 31, 2026
Fidelity Growth and Income Portfolio689KUS$177MJul 31, 2026
Fidelity OTC Portfolio671KUS$172MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Vanguard International Growth Fund653KUS$192MMay 31, 2026
Fidelity Puritan Fund599KUS$176MMay 31, 2026
Fidelity Balanced Fund482KUS$141MMay 31, 2026
T. Rowe Price Overseas Stock Fund478KUS$123MJul 31, 2026
Fidelity International Index Fund476KUS$140MMay 31, 2026
Fidelity Advisor New Insights Fund465KUS$139MJun 30, 2026
iShares MSCI EAFE ETF437KUS$112MJul 31, 2026
Fidelity Large Cap Stock Fund433KUS$111MJul 31, 2026
Fidelity Advisor Equity Growth Fund407KUS$119MMay 31, 2026
Select Health Care Portfolio400KUS$117MMay 31, 2026
ClearBridge International Growth Fund391KUS$100MJul 31, 2026
VIP Contrafund Portfolio362KUS$108MJun 30, 2026
Select Biotechnology Portfolio358KUS$105MMay 31, 2026
Fidelity Growth Company Fund329KUS$96.6MMay 31, 2026
VIP Growth Portfolio321KUS$96.1MJun 30, 2026
Fidelity Contrafund K6315KUS$94.2MJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account303KUS$90.6MJun 30, 2026
Vanguard International Core Stock Fund290KUS$86.7MJun 30, 2026
Vanguard European Stock Index Fund287KUS$73.6MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund285KUS$73.2MJul 31, 2026
Artisan International Fund270KUS$80.7MJun 30, 2026
Schwab International Equity ETF265KUS$77.8MMay 31, 2026
Select Pharmaceuticals Portfolio260KUS$76.4MMay 31, 2026
Fidelity Series Opportunistic Insights Fund256KUS$76.6MJun 30, 2026
Strategic Advisers International Fund253KUS$74.4MMay 31, 2026
Fidelity Advisor Capital Development Fund252KUS$75.5MJun 30, 2026
Fidelity Series Global ex U.S. Index Fund242KUS$62.1MJul 31, 2026
International Growth Fund242KUS$72.3MJun 30, 2026
Fidelity International Discovery Fund237KUS$61MJul 31, 2026
Fidelity Series International Value Fund218KUS$56.1MJul 31, 2026
VIP Mid Cap Portfolio210KUS$63MJun 30, 2026
Fidelity Diversified International Fund207KUS$53.1MJul 31, 2026
Nuveen International Equity Index Fund198KUS$50.9MJul 31, 2026
Vanguard International Dividend Appreciation Index Fund197KUS$50.6MJul 31, 2026
iShares MSCI EAFE Growth ETF187KUS$48MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF186KUS$55.6MJun 30, 2026
Fidelity Mega Cap Stock Fund183KUS$54.6MJun 30, 2026
Fidelity Mid-Cap Stock Fund180KUS$46.4MJul 31, 2026
International Core Equity 2 Portfolio179KUS$46MJul 31, 2026
Fidelity SAI International SMA Completion Fund176KUS$45.3MJul 31, 2026

This page holds 50 of 482 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alistair HenryExecutive Vice President & Chief Scientific Officer · Since at least May 7, 2026
Anna ClarkCorporate Communications, Media Relations · Since at least Jun 2, 2026
Antje WitteInvestor Relations · Since at least Aug 5, 2026
Cédric van RijckevorselDirector · Since at least Apr 30, 2026
Charles-Antoine JanssenDirector, Vice-chair of the Board · Since at least Nov 6, 2026
Cyril JanssenDirector · Since at least Nov 6, 2026
Denelle J. Waynick JohnsonExecutive Vice President & General Counsel · Since at least Nov 6, 2026
Dolca ThomasIndependent Director · Since at least Nov 6, 2026
Emmanuel CaeymaexExecutive Vice President · Since at least Nov 6, 2026
Fayos AlonsoCorporate Communications, Media Relations · Since at least Jun 17, 2026
All 27 people
PersonSeat
Fiona du MonceauExecutive Vice President, Chief Commercial Officer · Since at least Jun 27, 2025
Fiona PowrieIndependent Director · Since at least Nov 6, 2026
Jacques MarbehantExecutive Vice President, Patient Supply · Since at least Nov 6, 2026
Jan BergerIndependent Director · Since at least Nov 6, 2026
Jean-Christophe TellierChief Executive Officer & Chairman of the Executive Committee · Since at least Aug 31, 2026
Jean Luc FleurialExecutive Vice President & Chief Human Resources Officer · Since at least Nov 6, 2026
Jonathan PeacockIndependent Director, Chair of the Board · Since at least Apr 30, 2026
Judy BrownIndependent Director, Chair of the Audit Committee · Since at least Apr 30, 2026
Laurent SchotsCorporate Communications, Media Relations · Since at least Sep 29, 2026
Maëlys CastellaIndependent Director · Since at least Nov 6, 2026
Nefertiti GreeneIndependent Director · Since at least Nov 6, 2026
Pierre GurdjianIndependent Director · Since at least Nov 6, 2026
Sahar YazdianCorporate Communications · Since at least Sep 30, 2026
Sandrine DufourExecutive Vice President, Chief Financial Officer · Since at least Jul 30, 2026
Stef HeylenDirector · Since at least Nov 6, 2026
Ulf WiinbergIndependent Director · Since at least Nov 6, 2026
Yvonne NaughtonInvestor Relations · Since at least Sep 30, 2026

Open People

Log in to ask 6ix AI your own questions about Ucb S.A.